Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MammoSite.

Martin Keisch1

  • 1Mount Sinai Medical Center, Department of Radiation Oncology, Miami Beach, FL 33140, USA. mkeisch@salick.com

Expert Review of Medical Devices
|November 19, 2005
PubMed
Summary
This summary is machine-generated.

MammoSite offers a new approach to breast irradiation, simplifying partial breast irradiation for early-stage breast cancer. This brachytherapy device provides an alternative to lengthy external beam radiation therapy courses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brachytherapy for Soft Tissue Sarcoma: Maintaining Local Control While Minimizing Complications.

Journal of surgical oncology·2024
Same author

Cost-Effectiveness Analysis of Ultra-Hypofractionated Whole Breast Radiation Therapy Alone Versus Hormone Therapy Alone or Combined Treatment for Low-Risk ER-Positive Early Stage Breast Cancer in Women Aged 65 Years and Older.

International journal of radiation oncology, biology, physics·2022
Same author

Cost-Effectiveness Analysis of No Adjuvant Therapy Versus Partial Breast Irradiation Alone Versus Combined Treatment for Treatment of Low-Risk DCIS: A Microsimulation.

JCO oncology practice·2021
Same author

Ultra-Short Fraction Schedules as Part of De-intensification Strategies for Early-Stage Breast Cancer.

Annals of surgical oncology·2021
Same author

Cost-effectiveness analysis of endocrine therapy alone versus partial-breast irradiation alone versus combined treatment for low-risk hormone-positive early-stage breast cancer in women aged 70 years or older.

Breast cancer research and treatment·2020
Same author

Radiation Therapy Without Hormone Therapy for Women Age 70 or Above with Low-Risk Early Breast Cancer: A Microsimulation.

International journal of radiation oncology, biology, physics·2019
Same journal

Challenges associated with device therapy for pediatric patients with sleep apnea.

Expert review of medical devices·2026
Same journal

Review of regulatory requirements for benefit - risk assessment for medical devices: uncovering existing methodologies.

Expert review of medical devices·2026
Same journal

Two sides to every wrist: trans-ulnar access for cardiac interventions.

Expert review of medical devices·2026
Same journal

Comparative review of coronary CT angiography versus conventional catheter angiography: diagnostic value, clinical outcomes, and underlying technical principles.

Expert review of medical devices·2026
Same journal

Assessing the MYNX CONTROL arterial vascular closure device after catheterization procedures that enter the body through the femoral arteries.

Expert review of medical devices·2026
Same journal

Efficacy of two anatomically preformed supraglottic devices, the BlockBuster Laryngeal mask airway and the Ambu AuraGain, for ventilation in anesthetised paralyzed pediatric patients: a randomized trial.

Expert review of medical devices·2026
See all related articles

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Devices

Background:

  • Early-stage breast cancer is common, with breast conservation therapy a preferred treatment.
  • Standard whole-breast irradiation following mastectomy is lengthy (6-7 weeks) and being challenged.
  • Physicians and patients seek alternatives to traditional external beam radiation therapy.

Purpose of the Study:

  • To introduce MammoSite, a novel brachytherapy applicator for breast irradiation.
  • To discuss its role in breast conservation therapy for early-stage breast carcinoma.
  • To review current clinical results and compare with alternative technologies.

Main Methods:

  • MammoSite facilitates direct application of radioactive materials (brachytherapy).
  • It is designed as an easier, quality-assured applicator for partial breast irradiation.

Related Experiment Videos

  • The study examines the background, clinical results, and alternative technologies.

    • Main Results:

    • MammoSite aims to improve acceptance and availability of partial breast irradiation.
    • It offers a potentially shorter treatment course compared to external beam radiation.
    • Clinical results of MammoSite in early-stage breast cancer management are reviewed.

    Conclusions:

    • MammoSite represents an advancement in brachytherapy for breast conservation.
    • It may provide a more convenient and efficient option for eligible patients.
    • Further review of clinical outcomes and alternative technologies is ongoing.